Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > T. Matthew Wiley > Profile

T. Matthew Wiley

Affiliations

  • Chief Commercial Officer at Bioxcel Therapeutics Inc. (BTAI), 2024-10-04
  • Chief Commercial Officer at Vyne Therapeutics Inc. (VYNE), 2021-04-02
  • Chief Commercial Officer at Foamix Pharmaceuticals Ltd. (FOMX), 2020-03-11
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Foamix Pharmaceuticals Ltd.
 FOMX $3.76 13,440 Officer 63,440 2019-03-05 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Bioxcel Therapeutics Inc.
 BTAI $0.55 6,272 Officer 19,011 2024-10-03 Filing
Bioxcel Therapeutics Inc.
 BTAI $0.69 215 Officer 4,033 2024-09-16 Filing
Bioxcel Therapeutics Inc.
 BTAI $1.26 244 Officer 3,498 2024-06-17 Filing
Bioxcel Therapeutics Inc.
 BTAI $2.64 1,008 Officer 2,992 2024-04-04 Filing